Drug interactions
Indacaterol-glycopyrronium + Neostigmine
Severity: Minor
Indacaterol-glycopyrronium and Neostigmine: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Neostigmine increases cholinergic activity while glycopyrronium blocks muscarinic receptors, so their effects partly oppose each other. Inhaled glycopyrronium has low systemic exposure, so the effect is usually small.
What this interaction means in plain words
Indacaterol-glycopyrronium and Neostigmine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Indacaterol-glycopyrronium belongs to Respiratory; Neostigmine belongs to Central Nervous System.
Why it happens
Pharmacodynamic antagonism between cholinesterase inhibition and muscarinic blockade.
What to do
No routine adjustment is needed; monitor for reduced neostigmine muscarinic effects or increased cholinergic symptoms if either drug is changed.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Indacaterol-glycopyrronium and Neostigmine, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Indacaterol-glycopyrronium
Other interactions of Neostigmine
Frequently asked questions
Can I take Indacaterol-glycopyrronium with Neostigmine?
MediHelp rates the interaction as minor. Indacaterol-glycopyrronium and Neostigmine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Neostigmine increases cholinergic activity while glycopyrronium blocks muscarinic receptors, so their effects partly oppose each other. Inhaled glycopyrronium has low systemic exposure, so the effect is usually small.
How serious is the interaction between Indacaterol-glycopyrronium and Neostigmine?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine adjustment is needed; monitor for reduced neostigmine muscarinic effects or increased cholinergic symptoms if either drug is changed.
What other medicines interact with Indacaterol-glycopyrronium?
MediHelp also lists interactions of Indacaterol-glycopyrronium with, for example, Amisulpride, Arformoterol, Arsenic trioxide. The full list is on the Indacaterol-glycopyrronium page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
